Large-scale testing (Phase 3)Study completedNCT01596335
What this trial is testing
Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
Who this might be right for
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Tanabe Pharma Corporation 31